Nod2 deficiency impairs inflammatory and epithelial aspects of the cutaneous wound-healing response

Journal of Pathology

Volumn 229, Issue 1, 2013, Pages 121-131

  Campbell, Laura ^a   Williams, Helen ^a   Crompton, Rachel A ^a   Cruickshank, Sheena M ^a   Hardman, Matthew J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

inflammation; Pattern recognition receptor; skin; wound healing

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CHEMOKINE RECEPTOR CXCR2; TOLL LIKE RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL MIGRATION; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; EPIDERMIS; EPITHELIUM; FEMALE; INFLAMMATION; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; WOUND HEALING; WOUND HEALING IMPAIRMENT;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DERMATITIS; FEMALE; GENOTYPE; KERATINOCYTES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHIL INFILTRATION; NEUTROPHILS; NOD2 SIGNALING ADAPTOR PROTEIN; PHENOTYPE; RECEPTORS, INTERLEUKIN-8B; SKIN; TIME FACTORS; TOLL-LIKE RECEPTOR 2; WOUND HEALING;

EID: 84872839188     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4095     Document Type: Article

References (53)

1. Lazarus GS, Cooper DM, Knighton DR, et al,. Definitions and guidelines for assessment of wounds and evaluation of healing. Wound Repair Regen 1994; 2: 165-170.
2. Medina A, Scott PG, Ghahary A, et al,. Pathophysiology of chronic nonhealing wounds. J Burn Care Rehabil 2005; 26: 306-319.
3. Ruckley CV,. Evidence-based management of patients with leg ulcers. J Wound Care 1997; 6: 442-444.
4. Dowd SE, Wolcott RD, Sun Y, et al,. Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP). PLoS One 2008; 3: e3326.
5. Ryan TJ,. Infection following soft tissue injury: its role in wound healing. Curr Opin Infect Dis 2007; 20: 124-128.
6. Inohara N, Ogura Y, Fontalba A, et al,. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 2003; 278: 5509-5512.
7. Girardin SE, Boneca IG, Viala J, et al,. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003; 278: 8869-8872.
8. Fritz JH, Ferrero RL, Philpott DJ, et al,. Nod-like proteins in immunity, inflammation and disease. Nat Immunol 2006; 7: 1250-1257.
9. Kanneganti TD, Lamkanfi M, Nunez G,. Intracellular NOD-like receptors in host defense and disease. Immunity 2007; 27: 549-559.
10. Kobayashi M, Yoshiki R, Sakabe J, et al,. Expression of toll-like receptor 2, NOD2 and dectin-1 and stimulatory effects of their ligands and histamine in normal human keratinocytes. Br J Dermatol 2009; 160: 297-304.
11. Chin AI, Dempsey PW, Bruhn K, et al,. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature 2002; 416: 190-194.
12. Kobayashi K, Inohara N, Hernandez LD, et al,. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 2002; 416: 194-199.
13. Strober W, Murray PJ, Kitani A, et al,. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol 2006; 6: 9-20.
14. Strober W, Watanabe T,. NOD2, an intracellular innate immune sensor involved in host defense and Crohn's disease. Mucosal Immunol 2011; 4: 484-495.
15. Hugot JP, Chamaillard M, Zouali H, et al,. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
16. Eckmann L, Karin M,. NOD2 and Crohn's disease: loss or gain of function? Immunity 2005; 22: 661-667.
17. Lesage S, Zouali H, Cezard JP, et al,. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002; 70: 845-857.
18. Miceli-Richard C, Lesage S, Rybojad M, et al,. CARD15 mutations in Blau syndrome. Nat Genet 2001; 29: 19-20.
19. Punzi L, Furlan A, Podswiadek M, et al,. Clinical and genetic aspects of Blau syndrome: a 25-year follow-up of one family and a literature review. Autoimmun Rev 2009; 8: 228-232.
20. Dhondt V, Hofman S, Dahan K, et al,. Leg ulcers: a new symptom of Blau syndrome? Eur J Dermatol 2008; 18: 635-637.
21. Lin Q, Fang D, Fang J, et al,. Impaired wound healing with defective expression of chemokines and recruitment of myeloid cells in TLR3-deficient mice. J Immunol 2011; 186: 3710-3717.
22. Dasu MR, Thangappan RK, Bourgette A, et al,. TLR2 expression and signaling-dependent inflammation impair wound healing in diabetic mice. Lab Invest 2011; 90: 1628-1636.
23. Pauleau AL, Murray PJ,. Role of nod2 in the response of macrophages to toll-like receptor agonists. Mol Cell Biol 2003; 23: 7531-7539.
24. Takeuchi O, Hoshino K, Kawai T, et al,. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 1999; 11: 443-451.
25. Ashcroft GS, Mills SJ, Lei K, et al,. Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor. J Clin Invest 2003; 111: 1309-1318.
26. Ashcroft GS, Mills SJ,. Androgen receptor-mediated inhibition of cutaneous wound healing. J Clin Invest 2002; 110: 615-624.
27. Wilson L, Fathke C, Isik F,. Tissue dispersion and flow cytometry for the cellular analysis of wound healing. Biotechniques 2002; 32: 548-551.
28. Emmerson E, Campbell L, Ashcroft GS, et al,. Unique and synergistic roles for 17β-estradiol and macrophage migration inhibitory factor during cutaneous wound closure are cell type specific. Endocrinology 2009; 150: 2749-2757.
29. Patel GK, Wilson CH, Harding KG, et al,. Numerous keratinocyte subtypes involved in wound re-epithelialization. J Invest Dermatol 2006; 126: 497-502.
30. Blakytny R, Jude E,. The molecular biology of chronic wounds and delayed healing in diabetes. Diabet Med 2006; 23: 594-608.
31. Richardson WM, Sodhi CP, Russo A, et al. Nucleotide-binding oligomerization domain-2 inhibits toll-like receptor-4 signaling in the intestinal epithelium. Gastroenterology 2010; 139: 904-917, 917, e901-906.
32. Shimada K, Chen S, Dempsey PW, et al,. The NOD/RIP2 pathway is essential for host defenses against Chlamydophila pneumoniae lung infection. PLoS Pathog 2009; 5: e1000379.
33. Watanabe T, Kitani A, Murray PJ, et al,. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 2004; 5: 800-808.
34. Rehman A, Sina C, Gavrilova O, et al,. Nod2 is essential for temporal development of intestinal microbial communities. Gut 2011; 60: 1354-1362.
35. Hruz P, Zinkernagel AS, Jenikova G, et al,. NOD2 contributes to cutaneous defense against Staphylococcus aureus through α-toxin-dependent innate immune activation. Proc Natl Acad Sci USA 2009; 106: 12873-12878.
36. Hagiwara S, Iwasaka H, Hasegawa A, et al,. Dendritic cell activation in response to ischemia-reperfusion injury of the small intestine. Surg Today 2010; 40: 137-145.
37. Rosenthal LA, Szakaly RJ, Amineva SP, et al,. Lower respiratory tract infection induced by a genetically modified picornavirus in its natural murine host. PLoS One 2012; 7: e32061.
38. Conforti-Andreoni C, Beretta O, Licandro G, et al,. Synergism of NOD2 and NLRP3 activators promotes a unique transcriptional profile in murine dendritic cells. J Leukoc Biol 2010; 88: 1207-1216.
39. Poole JA, Kielian T, Wyatt TA, et al,. Organic dust augments nucleotide-binding oligomerization domain expression via an NF-κB pathway to negatively regulate inflammatory responses. Am J Physiol Lung Cell Mol Physiol 2011; 301: L296-306.
40. Rosenzweig HL, Galster K, Vance EE, et al,. NOD2 deficiency results in increased susceptibility to peptidoglycan-induced uveitis in mice. Invest Ophthalmol Vis Sci 2011; 52: 4106-4112.
41. Vieira SM, Cunha TM, Franca RF, et al. Joint NOD2/RIPK2 signaling regulates IL-17 axis and contributes to the development of experimental arthritis. J Immunol 2012; 188: 5116-5122.
42. Finney CA, Lu Z, LeBourhis L, et al,. Disruption of Nod-like receptors alters inflammatory response to infection but does not confer protection in experimental cerebral malaria. Am J Trop Med Hyg 2009; 80: 718-722.
43. Devalaraja RM, Nanney LB, Du J, et al,. Delayed wound healing in CXCR2 knockout mice. J Invest Dermatol 2000; 115: 234-244.
44. Gillitzer R, Goebeler M,. Chemokines in cutaneous wound healing. J Leukoc Biol 2001; 69: 513-521.
45. Singer AJ, Clark RA,. Cutaneous wound healing. N Engl J Med 1999; 341: 738-746.
46. Mahdavian Delavary B, van der Veer WM, van Egmond M, et al. Macrophages in skin injury and repair. Immunobiology 2011; 216: 753-762.
47. Kim JY, Omori E, Matsumoto K, et al,. TAK1 is a central mediator of NOD2 signaling in epidermal cells. J Biol Chem 2008; 283: 137-144.
48. Adams S, Valchanova RS, Munz B,. RIP2: a novel player in the regulation of keratinocyte proliferation and cutaneous wound repair? Exp Cell Res 2010; 316: 728-736.
49. Dahiya Y, Pandey RK, Sodhi A,. Nod2 downregulates TLR2/1 mediated IL-1β gene expression in mouse peritoneal macrophages. PLoS One 2011; 6: e27828.
50. Watanabe T, Asano N, Murray PJ, et al,. Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. J Clin Invest 2008; 118: 545-559.
51. Macedo L, Pinhal-Enfield G, Alshits V, et al,. Wound healing is impaired in MyD88-deficient mice: a role for MyD88 in the regulation of wound healing by adenosine A2A receptors. Am J Pathol 2007; 171: 1774-1788.
52. Lai Y, Di Nardo A, Nakatsuji T, et al,. Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat Med 2009; 15: 1377-1382.
53. Sato T, Yamamoto M, Shimosato T, et al,. Accelerated wound healing mediated by activation of Toll-like receptor 9. Wound Repair Regen 2010; 18: 586-593.